SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-324626
Filing Date
2018-11-13
Accepted
2018-11-13 06:12:05
Documents
3
Period of Report
2018-11-11
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d601776d8k.htm 8-K 39633
2 EX-99.1 d601776dex991.htm EX-99.1 16024
3 GRAPHIC g601776g1112142813811.jpg GRAPHIC 4487
  Complete submission text file 0001193125-18-324626.txt   63306
Mailing Address 8000 MARINA BOULEVARD SUITE 300 BRISBANE CA 94005-1884
Business Address 8000 MARINA BOULEVARD SUITE 300 BRISBANE CA 94005-1884 (650) 614-5220
Aimmune Therapeutics, Inc. (Filer) CIK: 0001631650 (see all company filings)

IRS No.: 452748244 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37519 | Film No.: 181174696
SIC: 2834 Pharmaceutical Preparations